Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 1;14(3):180-185.
doi: 10.5152/ejbh.2018.3946. eCollection 2018 Jul.

Favorable Long-Term Outcome in Male Breast Cancer

Enver Özkurt  1   2 , Mustafa Tükenmez  1 , Ravza Yılmaz  3 , Neslihan Cabioğlu  1 , Mahmut Müslümanoğlu  1 , Ahmet Said Dinççağ  1 , Abdullah İğci  1 , Vahit Özmen  1
Affiliations

Favorable Long-Term Outcome in Male Breast Cancer

Enver Özkurt et al. Eur J Breast Health. .

Abstract

Objective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the male population. Data is usually extrapolated from female breast cancer (FBC) studies. We aim to study the clinicopathological characteristics and outcome of MBC patients at our institution and we aim to emphasize the differences compared with FBC.

Materials and methods: Between January 1993 and April 2016, 56 male patients who were diagnosed as breast cancer and underwent surgical operation were retrospectively analyzed. Patients were evaluated for demographical characteristics, surgery type, clinicopathological characteristics, adjuvant and neoadjuvant treatments, follow-up time, overall survival (OS), disease free survival (DFS), and disease specific survival (DSS).

Results: The ratio of MBC among all breast cancers at our institution is 1%. The median age was 64 (34-85). Surgical procedures were modified radical mastectomy (MRM) in 41 patients (77%), simple mastectomy in 11 patients (21%), and lumpectomy in 1 patient (2%). Two patients were Stage 0 (4%), 7 were Stage 1 (13%), 12 were Stage 2 (22.6%), and 32 were Stage 3 (60.4%). Molecular subtypes of the invasive tumors were luminal A in 40 (80%), luminal B in 6 (12%), HER-2 type in 1 (2%), and basal-like in 3 (6%). Median follow-up time was 77 (3-287) months. 5-year and 10-year OS, DFS, and DSS rates were 80.7%, 96%, 95.6% and 71.6%, 81.9%, 91.7% respectively.

Conclusion: MBC presents different clinicopathological and prognostic factors when compared to FBC. Our survival rates are higher than the average presented in available literature. Because of the high rate of hormone receptor positivity, hormonal therapy is the mainstay for the treatment of estrogen receptor (ER)+ male breast cancer.

Keywords: Breast neoplasm; disease-free survival; male; survival rate.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Physical examination finding of a 45 year-old male showing ulceration around his nipple
Figure 2. a, b
Figure 2. a, b
Mammography imaging of a 65 year-old male patient with a malignant mass on his right breast. MLO mammography (a), CC mammography (b)
See this image and copyright information in PMC

References

    1. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: A population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232–239. doi: 10.1200/JCO.2009.23.8162. - DOI - PMC - PubMed
    1. Gradishar WJ. Male breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborn CK, editors. Disease of the Breast. Philedelphia: Lippincott Williams and Wilkins; 2000. pp. 661–667.
    1. İğci Abdullah, Tükenmez Mustafa, Özkurt Enver. Male Breast Cancer. In: Aydıner Adnan, İğci Abdullah, Soran Atilla., editors. Breast Disease Volume II: Management and Therapies. Switzerland: Springer; 2016. pp. 389–405. - DOI
    1. Tahmasebi S, Akrami M, Omidvari S, Salehi A, Talei A. Male breast cancer; analysis of 58 cases in Shiraz, South of Iran. Breast Dis. 2010;31:29–32. doi: 10.3233/BD-2009-0293. - DOI - PubMed
    1. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002;137:678–687. doi: 10.7326/0003-4819-137-8-200210150-00013. - DOI - PubMed

LinkOut - more resources